How should I evaluate and manage a 71-year-old patient who has normal fasting plasma glucose but marked glucosuria (~1000 mg/dL)?

Evaluation and Management of Glucosuria with Normal Fasting Glucose

This patient most likely has renal glucosuria, a benign condition caused by reduced renal glucose reabsorption threshold, and does not require diabetes treatment but does warrant confirmation that diabetes is truly absent.

Immediate Diagnostic Steps

Rule out diabetes with additional testing beyond fasting glucose alone:

• Obtain an HbA1c measurement, which should be <5.7% if diabetes is absent 1.
• Consider a 2-hour oral glucose tolerance test (OGTT) with 75g glucose load, as fasting glucose alone misses a substantial proportion of diabetes cases, particularly in older adults 1.
• The OGTT is especially important because fasting glucose has lower sensitivity (46.9% in those 50-64 years, only 28.5% in those 65-79 years) for detecting diabetes compared to post-load glucose 2.

Key diagnostic thresholds to apply:

• Diabetes is confirmed if HbA1c ≥6.5% OR 2-hour OGTT glucose ≥200 mg/dL (11.1 mmol/L) 1.
• If both tests remain normal, the diagnosis is renal glucosuria rather than diabetes 3, 4.

Understanding Renal Glucosuria

This condition represents a lowered renal threshold for glucose reabsorption:

• Normal kidneys reabsorb glucose until plasma levels exceed approximately 180 mg/dL 5.
• In renal glucosuria, glucose appears in urine at normal or even low plasma glucose concentrations 5.
• The condition is typically benign and requires no treatment 5.

Important clinical context for this 71-year-old patient:

• 73% of individuals with persistent glucosuria and normal glucose tolerance have a positive family history of diabetes 5.
• 61% are obese, and these patients show significantly higher fasting and 60-minute post-load glucose levels (though still within normal range) 5.
• This patient warrants closer diabetes surveillance given age >65 years and the glucosuria finding 1.

Confirm the Diagnosis is Not Diabetes

Ensure proper sample handling to avoid false-normal fasting glucose:

• Plasma samples must be centrifuged and separated immediately after collection; delays cause falsely low glucose values 3.
• Fasting is defined as no caloric intake for at least 8 hours 1, 3.

Recognize day-to-day glucose variability:

• Fasting glucose shows 12-15% day-to-day variability 3.
• Among individuals with one normal fasting glucose measurement, 40% would be reclassified as prediabetes and 3% as diabetes based on repeated measurements 6.
• Therefore, repeat testing is essential when results are near diagnostic thresholds 1, 3.

If Diabetes is Confirmed Despite Normal Initial Fasting Glucose

Initiate treatment immediately—do not delay:

• Start metformin as first-line therapy unless contraindicated (eGFR <30 mL/min/1.73m²) 1, 4.
• For eGFR 30-60 mL/min/1.73m², use lower metformin doses and monitor renal function more frequently 1.
• Do not postpone pharmacologic treatment awaiting lifestyle modification alone; current guidelines recommend starting medication at diagnosis 4.

Set an HbA1c target:

• For most adults, target HbA1c <7% 1, 4.
• For patients with short disease duration, long life expectancy, no complications, and low hypoglycemia risk, consider a more stringent target of <6.5% 4.
• For older adults with extensive comorbidities or limited life expectancy, a less stringent target of <8% may be appropriate 1.

Intensify therapy if targets are not met:

• Review glycemic control every 3 months 4.
• Add a second agent (sulfonylurea, DPP-4 inhibitor, SGLT2 inhibitor, GLP-1 receptor agonist, or basal insulin) if HbA1c remains above target after 3 months 4.
• When presenting HbA1c is 1.5-2.0% above target, initiate combination therapy (metformin + second agent) rather than sequential monotherapy 4.

If Diabetes is Excluded

Provide reassurance but maintain surveillance:

• Renal glucosuria itself requires no treatment 5.
• However, this patient has prediabetes risk factors (age 71, glucosuria suggesting possible early metabolic dysfunction) 5.
• Repeat diabetes screening (HbA1c, fasting glucose, or OGTT) every 1-3 years depending on additional risk factors (obesity, family history, hypertension) 1.

Common Pitfalls to Avoid

• Do not rely solely on fasting glucose in older adults; it misses >70% of diabetes cases in those >65 years 2.
• Do not assume glucosuria always indicates diabetes; renal glucosuria is a distinct benign entity 5.
• Do not attribute glucosuria to SGLT2 inhibitors unless the patient is actually taking one of these medications 7.
• Do not delay confirmatory testing; perform HbA1c and/or OGTT within days to weeks, not months 3, 4.